Home > Search Clinical Trials > All > Trial Details

Clinical Trial Details
Adaptive Treatment for Adolescent Cannabis Use Disorders
Clinical Trial ( IRB ) #: 12-078H-3
Title: Adaptive Treatment for Adolescent Cannabis Use Disorders
Principal Investigator: Dr. Yifrah Kaminer
Description: The proposed study will examine an Adaptive Treatment approach in order to improve outcomes of youth with Cannabis Use Disorder who are poor responders to treatment. The study will address the current contrasts in youth response to treatment, the problem of poor response and the prevention of relapse. Youth (N=230) between 13-18 years of age who have met the DSM-IV diagnosis for Cannabis Use Disorder will participate in the initial intervention which includes: two individual sessions of Motivational Enhancement Therapy (MET) followed by five group sessions of Cognitive Behavioral Therapy (CBT). Following the initial intervention only those considered “poor responders” will be randomized into one of two AT conditions, either 10 weekly individualized CBT sessions or the Adolescent Community Reinforcement Approach (ACRC-10). The ACRA includes six individual, two parent and two joint weekly sessions. Outcomes will be measured for all participants at baseline (entry to treatment), 17 weeks (end of AT Phase), 21, 25, 38 and 52 weeks form onset of treatment. Poor responders fall into two categories, those who failed to achieve negative drug urinalysis during the last session of the initial MET?CBT-7 treatment they attended, and those who either dropped out or were administratively discharged at any time during the initial MET/CBT-7 treatment. Participants will be eligible to receive a total of $150 for full participation in the study.
Classification:
  Addiction/Substance Abuse
Eligibility Criteria: Check with study contact
How to Contact: Rebecca Burke. Rebecca Burke. Telephone: Not available. Email: burke@uchc.edu
Enrollment Status/Comments: Enrolling/recruiting. For current recruitment status, please check with study contact.